Coalition aims to improve cancer drug access in poorer nations Several of the top pharmaceutical companies have joined a new coalition that aims to improve access to cancer Share X Coalition aims to improve cancer drug access in poorer nations https://pharmaphorum.com/news/coalition-aims-to-improve-cancer-drug-access-in-poorer-nations/
EU imposes Horizon funding block on UK scientists UK scientists are being denied from joining the €95 billion Horizon research funding programme as a dispute over Share X EU imposes Horizon funding block on UK scientists https://pharmaphorum.com/news/eu-imposes-horizon-funding-block-on-uk-scientists/
Sleepio app for insomnia backed by NICE After a non-committal appraisal of Big Health’s Sleepio app for insomnia last November in draft guidance from NICE, Share X Sleepio app for insomnia backed by NICE https://pharmaphorum.com/news/sleepio-app-for-insomnia-backed-by-nice/
Large UK study suggests vaccination helps treat long COVID An observational study in the UK has found evidence that COVID-19 vaccination can help alleviate the lingering symptoms Share X Large UK study suggests vaccination helps treat long COVID https://pharmaphorum.com/news/large-uk-study-suggests-vaccination-helps-treat-long-covid/
Beckley adds digital element to its psychedelic drug trials Phase 2 trials of Beckley Psytech’s psychedelic drug candidates will make use of digital technologies for patient monitoring, Share X Beckley adds digital element to its psychedelic drug trials https://pharmaphorum.com/news/beckley-adds-digital-element-to-its-psychedelic-drug-trials/
Moderna’s HIV vaccine prepped for trials in Africa Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV Share X Moderna’s HIV vaccine prepped for trials in Africa https://pharmaphorum.com/news/modernas-hiv-vaccine-prepped-for-trials-in-africa/
Pharma bad boy Martin Shkreli is on the streets again Former pharma executive Martin Shkreli, who became notorious for raising the price of a lifesaving AIDS drug by Share X Pharma bad boy Martin Shkreli is on the streets again https://pharmaphorum.com/news/pharma-bad-boy-martin-shkreli-is-on-the-streets-again/
Merck snaps up cancer drug from China’s Kelun in $1.4bn deal Merck & Co has quietly added another drug to its immuno-oncology pipeline via an agreement with China’s Sichuan Share X Merck snaps up cancer drug from China’s Kelun in $1.4bn deal https://pharmaphorum.com/news/merck-snaps-up-cancer-drug-from-chinas-kelun-in-1-4bn-deal/
SwanBio raises $56m for rare neurological disease gene therapy SwanBio Therapeutics has raised $56 million in a second-round financing that will be used to advance its lead Share X SwanBio raises $56m for rare neurological disease gene therapy https://pharmaphorum.com/news/swanbio-raises-56m-for-rare-neurological-disease-gene-therapy/
Digital health body publishes best practice guide for DTx developers Companies trying to bring digital therapeutic (DTx) products through development and into the market have been navigating in Share X Digital health body publishes best practice guide for DTx developers https://pharmaphorum.com/news/digital-health-body-publishes-best-practice-guide-for-dtx-developers/
AstraZeneca buys into startup RQ Bio’s COVID antibodies Brand new UK startup RQ Biotechnology has been thrust into the spotlight after signing a $157 million licensing Share X AstraZeneca buys into startup RQ Bio’s COVID antibodies https://pharmaphorum.com/news/astrazeneca-buys-into-startup-rq-bios-covid-antibodies/
NICE endorses Magtrace diagnostic to detect breast cancer spread Women with breast cancer in England and Wales will soon be able to access a new diagnostic based Share X NICE endorses Magtrace diagnostic to detect breast cancer spread https://pharmaphorum.com/news/nice-endorses-magtrace-diagnostic-to-detect-breast-cancer-spread/
Google gives ex-FDA digital health head Bakul Patel strategic role FDA veteran Bakul Patel has joined Google as its new senior director of global digital health strategy, ending Share X Google gives ex-FDA digital health head Bakul Patel strategic role https://pharmaphorum.com/news/google-gives-ex-fda-digital-health-head-bakul-patel-strategic-role/
AbbVie and Cugene partner to tackle autoimmune diseases AbbVie and Cugene have teamed up to research autoimmune diseases and cancer in an exclusive worldwide agreement. The Share X AbbVie and Cugene partner to tackle autoimmune diseases https://pharmaphorum.com/news/abbvie-and-cugene-partner-to-tackle-autoimmune-diseases/
BenevolentAI, AstraZeneca AI-based drug discovery collaboration achieves third milestone BenevolentAI has discovered a second novel target for idiopathic pulmonary fibrosis (IPF), which AstraZeneca has added to its Share X BenevolentAI, AstraZeneca AI-based drug discovery collaboration achieves third milestone https://pharmaphorum.com/news/benevolentai-astrazeneca-ai-based-drug-discovery-collaboration-achieves-third-milestone/
AstraZeneca extends oncology partnership with Proteros AstraZeneca has boosted its research capacity by extending its oncology partnership with Proteros biostructures. German pharma firm Proteros Share X AstraZeneca extends oncology partnership with Proteros https://pharmaphorum.com/news/astrazeneca-extends-oncology-partnership-with-proteros/
Accelerator aims to promote digital health innovation in Italy A digital health startup accelerator is launching in Italy, with more than €6 million backing the new enterprise. Share X Accelerator aims to promote digital health innovation in Italy https://pharmaphorum.com/digital/accelerator-aims-to-promote-digital-health-innovation-in-italy/
Novel drug to tackle inflammatory diseases begins trial An early-stage drug that is being developed to tackle inflammatory and autoimmune diseases has been approved by the Share X Novel drug to tackle inflammatory diseases begins trial https://pharmaphorum.com/news/novel-drug-to-tackle-inflammatory-diseases-begins-trial/
KOL Validation: An Opportunity To Benchmark Mindset Share X KOL Validation: An Opportunity To Benchmark Mindset https://pharmaphorum.com/partner-content/kol-validation-an-opportunity-to-benchmark-mindset/
Content Factory 24/7: Viseven adds a Center of Excellence in India to provide around-the-clock global support for its clients Share X Content Factory 24/7: Viseven adds a Center of Excellence in India to provide around-the-clock global support for its clients https://pharmaphorum.com/partner-content/content-factory-24-7-viseven-adds-a-center-of-excellence-in-india-to-provide-around-the-clock-global-support-for-its-clients/
4 Reasons Why You Shouldn’t Ignore CDISC Data Standards Share X 4 Reasons Why You Shouldn’t Ignore CDISC Data Standards https://pharmaphorum.com/partner-content/4-reasons-why-you-shouldnt-ignore-cdisc-data-standards/
How to Provide Value that Benefits Patients (and Your Brand) Share X How to Provide Value that Benefits Patients (and Your Brand) https://pharmaphorum.com/partner-content/how-to-provide-value-that-benefits-patients-and-your-brand/
AXON hires a Global Healthcare Insights and Strategy Lead Share X AXON hires a Global Healthcare Insights and Strategy Lead https://pharmaphorum.com/partner-content/axon-hires-a-global-healthcare-insights-and-strategy-lead/
Performance-io hires Lonneke Feskens to lead Europe Share X Performance-io hires Lonneke Feskens to lead Europe https://pharmaphorum.com/partner-content/performance-io-hires-lonneke-feskens-to-lead-europe/
